Predictive Oncology Price to Book Ratio 2010-2023 | POAI
Historical price to book ratio values for Predictive Oncology (POAI) over the last 10 years. The current price to book ratio for Predictive Oncology as of May 01, 2024 is 0.69.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Predictive Oncology Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2024-05-01 | 1.65 | 0.81 | |
| 2023-12-31 | 3.29 | $2.04 | 1.62 |
| 2023-09-30 | 3.20 | $2.89 | 1.11 |
| 2023-06-30 | 4.86 | $3.67 | 1.32 |
| 2023-03-31 | 6.54 | $4.67 | 1.40 |
| 2022-12-31 | 6.13 | $5.53 | 1.11 |
| 2022-09-30 | 7.20 | $7.55 | 0.95 |
| 2022-06-30 | 8.20 | $8.58 | 0.96 |
| 2022-03-31 | 19.54 | $11.28 | 1.73 |
| 2021-12-31 | 19.04 | $12.27 | 1.55 |
| 2021-09-30 | 26.60 | $14.60 | 1.82 |
| 2021-06-30 | 26.20 | $16.25 | 1.61 |
| 2021-03-31 | 24.20 | $14.57 | 1.66 |
| 2020-12-31 | 14.65 | $2.67 | 5.49 |
| 2020-09-30 | 16.28 | $14.75 | 1.10 |
| 2020-06-30 | 32.80 | $17.73 | 1.85 |
| 2020-03-31 | 31.51 | $35.38 | 0.89 |
| 2019-12-31 | 52.20 | $55.37 | 0.94 |
| 2019-09-30 | 101.00 | $131.53 | 0.77 |
| 2019-06-30 | 149.50 | $143.93 | 1.04 |
| 2019-03-31 | 150.00 | $0.81 | 185.99 |
| 2018-12-31 | 123.82 | $0.76 | 163.16 |
| 2018-09-30 | 212.00 | $45.18 | 4.69 |
| 2018-06-30 | 226.00 | $55.62 | 4.06 |
| 2018-03-31 | 220.00 | $88.37 | 2.49 |
| 2017-12-31 | 202.00 | $77.54 | 2.61 |
| 2017-09-30 | 290.72 | $73.22 | 3.97 |
| 2017-06-30 | 294.00 | $103.39 | 2.84 |
| 2017-03-31 | 420.00 | $122.75 | 3.42 |
| 2016-12-31 | 560.00 | $40.48 | 13.84 |
| 2016-09-30 | 825.00 | $0.68 | 1219.87 |
| 2016-06-30 | 762.50 | $50.53 | 15.09 |
| 2016-03-31 | 862.50 | $237.65 | 3.63 |
| 2015-12-31 | 14700.00 | $19.77 | 743.63 |
| 2015-09-30 | 16070.00 | $1.12 | 14366.17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.006B | $0.002B |
| Predictive Oncology Inc. is focused on applying artificial intelligence to personalized medicine and drug discovery. Its operating business unit consists of Helomics, TumorGenesis and Skyline Medical. Predictive Oncology Inc., formerly known as Precision Therapeutics Inc., is based in MINNEAPOLIS. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $34.790B | 19.11 |
| Inspire Medical Systems (INSP) | United States | $7.322B | 0.00 |
| 10x Genomics (TXG) | United States | $3.489B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.410B | 0.00 |
| Axonics (AXNX) | United States | $3.396B | 0.00 |
| Enovis (ENOV) | United States | $3.029B | 23.01 |
| Azenta (AZTA) | United States | $2.925B | 238.46 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.864B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.685B | 0.00 |
| Privia Health (PRVA) | United States | $2.183B | 96.84 |
| Schrodinger (SDGR) | United States | $1.763B | 0.00 |
| Omnicell (OMCL) | United States | $1.231B | 30.12 |
| Phreesia (PHR) | United States | $1.169B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.817B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.783B | 0.00 |
| Standard BioTools (LAB) | United States | $0.719B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.608B | 0.00 |
| Talkspace (TALK) | United States | $0.519B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.367B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.333B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.312B | 0.00 |
| Pulmonx (LUNG) | United States | $0.293B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.170B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.162B | 0.00 |
| American Well (AMWL) | United States | $0.148B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.139B | 0.00 |
| Augmedix (AUGX) | United States | $0.133B | 0.00 |
| Outset Medical (OM) | United States | $0.131B | 0.00 |
| TruBridge (TBRG) | United States | $0.116B | 4.94 |
| 111 (YI) | China | $0.087B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.073B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.071B | 0.00 |
| HeartBeam (BEAT) | United States | $0.053B | 0.00 |
| Zepp Health (ZEPP) | China | $0.052B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.047B | 0.00 |
| Movano (MOVE) | United States | $0.044B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.034B | 0.00 |
| Akili (AKLI) | United States | $0.031B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.025B | 0.00 |
| Cue Health (HLTH) | United States | $0.022B | 0.00 |
| CareCloud (CCLD) | United States | $0.018B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
| ETAO (ETAO) | United States | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.013B | 0.00 |
| Transgenomic (PRPO) | United States | $0.008B | 0.00 |
| HeartSciences (HSCS) | United States | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.006B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.006B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |